long covid

  1. SNT Gatchaman

    Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity & Early Mortality Prediction,2023,Lodge

    Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction Lodge, Samantha; Lawler, Nathan G.; Gray, Nicola; Masuda, Reika; Nitschke, Philipp; Whiley, Luke; Bong, Sze-How; Yeap, Bu B.; Dwivedi, Girish; Spraul...
  2. E

    Disease Modifying Therapy (IMU-838) to be trialled in Long Covid

    A team in Germany is planning to launch a trial with the drug IMU-838 trial for Long Covid. Currently there aren’t too many details on the trial, however Maria Vehreschild of the Universitätsklinikum Frankfurt has given some details in this talk www.vimeo.com/873993707/description (from 32:30...
  3. SNT Gatchaman

    Prolonged platelet hyperactivity after COVID-19 infection, 2023, Nara et al.

    Prolonged platelet hyperactivity after COVID-19 infection Noriko Nara; Mie Shimizu; Masahiro Yamamoto; Tomoki Nakamizo; Azusa Hayakawa; Ken Johkura Platelet hyperactivity often occurs in patients with coronavirus disease 2019 (COVID-19). However, it remains unclear how long platelet...
  4. E

    People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function, 2023, McLaughlin+

    People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function Background This study aimed to compare flow-mediated dilation values between individuals with Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome...
  5. SNT Gatchaman

    Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry, 2023, Bendella et al.

    Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry Bendella, Zeynep; Widmann, Catherine Nichols; Layer, Julian Philipp; Layer, Yonah Lucas; Haase, Robert; Sauer, Malte; Bieler, Luzie; Lehnen, Nils Christian; Paech, Daniel; Heneka...
  6. SNT Gatchaman

    Review Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19, 2023, Nair et al.

    Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19 Nair, Soumyalekshmi; Nova-Lamperti, Estefania; Labarca, Gonzalo; Kulasinghe, Arutha; Short, Kirsty R.; Carrión, Flavio; Salomon, Carlos COVID-19 continues to affect an unprecedented number...
  7. SNT Gatchaman

    Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection PASC neurologic symptoms: A case-control pilot study,2023,Wright

    Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection PASC neurologic symptoms: A case-control pilot study Wright; Pyles; Sheffield-Moore; Deer; Randolph; McGovern; Danesi; Gilkison; Ward; Vargas; Armstrong; Lindsay; Zaidan; Seashore; Wexler; Masel; Urban...
  8. E

    Utility of 2-day Cardiopulmonary Exercise Testing Protocol in LONG-HAUL COVID (LHC) PATIENTS: PRELIMINARY DATA, 2023, Abbasi et al

    UTILITY OF 2-DAY CARDIOPULMONARY EXERCISE TESTING PROTOCOL IN LONG-HAUL COVID (LHC) PATIENTS: PRELIMINARY DATA Purpose: Long Haul COVID (LHC) patients have prominent symptoms of fatigue and exercise limitation. Comparisons have been made between Chronic Fatigue Syndrome/Myalgic...
  9. E

    Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation..., Hellemonds+

    Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity Background: Many patients with SARS-CoV-2 infection develop long COVID with fatigue as one of the most disabling...
  10. SNT Gatchaman

    SARS-CoV-2 spike antigen-specific B cell and antibody responses in convalescent males and females with or without post-covid condition, 2023, Limoges+

    SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition Limoges, Marc-André; Quenum, Akouavi Julite Irmine; Chowdhury, Mohammad Mobarak Hussain; Rexhepi, Fjolla; Namvarpour, Mozhdeh...
  11. Andy

    Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 2023 Bonilla et al

    Highlights The off-label use of low-dose naltrexone (LDN) is a potential drug intervention for the management of post-COVID conditions. LDN has anti-inflammatory and immunomodulatory properties which may benefit those with PASC where persistent inflammation is the causative pathway. LDN...
  12. Andy

    Remission of severe forms of Long Covid following monoclonal antibody (MCA) infusions: A report of signal index cases..., 2024, Scheppke, Klimas et al

    Note: title change in final publication - see post below Preprint Pathophysiology and potential treatment of long COVID: A report of signal index cases and call for targeted research, 2023, Scheppke, Klimas et al Objective Long COVID has afflicted tens of millions globally leaving many...
  13. SNT Gatchaman

    Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19, 2023, Lim et al.

    Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19 Sung Ha Lim; Hyun Jeong Ju; Ju Hee Han; Ji Hae Lee; Won-Soo Lee; Jung Min Bae; Solam Lee Importance Multiple cases of autoimmune and autoinflammatory diseases after COVID-19 have been reported. However, their...
  14. E

    Virtual reality for assessing stereopsis performance and eye characteristics in Post-COVID, 2023, Mehringer, Hohberger et al

    Virtual reality for assessing stereopsis performance and eye characteristics in Post-COVID Abstract In 2019, we faced a pandemic due to the coronavirus disease (COVID-19), with millions of confirmed cases and reported deaths. Even in recovered patients, symptoms can be persistent over weeks...
  15. SNT Gatchaman

    Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women, 2023, Price et al.

    Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women Jillian Kallman Price; Leyla de Avila; Maria Stepanova; Ali A Weinstein; Huong Pham; Wisna’odom Keo; Andrei Racila; Suzannah Gerber; Brian P Lam; Lynn H Gerber; Zobair M Younossi Introduction...
  16. Sly Saint

    Webinar: Long Covid Misconceptions with Dr Charles Shepherd and People with Lived Experience 11 November at 1pm

    register for event at link Webinar: Long Covid Misconceptions with Dr Charles Shepherd and People with Lived Experience - The ME Association
  17. SNT Gatchaman

    Clinical Features and Follow-up of Referred Children and Young People With Long COVID, 2023, Weakley et al.

    Clinical Features and Follow-up of Referred Children and Young People With Long COVID Weakley, Kathryn E.;Schikler, Allegra;Green, Julianne V.;Blatt, Daniel B.;Barton, Shanna M.;Statler, Victoria A.;Feygin, Yana;Marshall, Gary S. Background: Patient-level data on the clinical features and...
  18. E

    Immune Correlates of Hyperglycemia and Vaccination in a Non-human Primate Model of Long-COVID, 2023, Palmer et al

    Immune Correlates of Hyperglycemia and Vaccination in a Non-human Primate Model of Long-COVID Abstract Hyperglycemia, and exacerbation of pre-existing deficits in glucose metabolism, are major manifestations of the post-acute sequelae of SARS-CoV-2 (PASC). Our understanding of lasting...
  19. SNT Gatchaman

    UK Long COVID Service Evaluation and Forward Planning, 2023, Bath, Swindon and Wiltshire

    YouTube - Long COVID Service Evaluation and Forward Planning: 28th September, 2023 I attended this webinar last night my time. It's posted already on YouTube. 70 minutes in three main sections. This was hosted by a company providing a digital patient reported outcomes measures platform...
  20. E

    No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache, 2023

    No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache Abstract Headache is one of the most common neurological manifestations of COVID-19, but it is unclear whether chronic headache as a symptom of...
Back
Top Bottom